Royal Bank of Canada reiterated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a research note issued to investors on Thursday, Benzinga reports. They currently have a $7.00 price objective on the stock. Other equities research analysts also recently issued reports about the stock. Stifel Nicolaus began coverage on shares […]

Royal Bank of Canada restated their sector perform rating on shares of Marshalls (LON:MSLH – Free Report) in a report published on Wednesday morning, Marketbeat reports. They currently have a GBX 370 ($4.89) price objective on the stock. Separately, Berenberg Bank reaffirmed a buy rating and set a GBX 420 ($5.55) price target on shares […]

Korro Bio (NASDAQ:KRRO – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Royal Bank of Canada in a report issued on Thursday, Benzinga reports. They presently have a $95.00 price objective on the stock. Royal Bank of Canada’s target price would suggest a potential upside of 161.49% from the company’s […]

Royal Bank of Canada reiterated their sector perform rating on shares of B2Gold (NYSE:BTG – Free Report) in a report published on Tuesday morning, Benzinga reports. They currently have a $3.75 target price on the stock. BTG has been the topic of a number of other research reports. Cibc World Mkts upgraded B2Gold from a […]

Royal Bank of Canada reaffirmed their sector perform rating on shares of APA (NASDAQ:APA – Free Report) in a research note released on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $41.00 price objective on the stock. A number of other research analysts also recently issued reports on APA. Bank of America […]